Literature DB >> 33128158

Management of premature ejaculation: a clinical guideline from the Italian Society of Andrology and Sexual Medicine (SIAMS).

A Sansone1, A Aversa2, G Corona3, A D Fisher4, A M Isidori5, S La Vignera6, E Limoncin1, M Maggi7, M Merico8, E A Jannini9.   

Abstract

Premature ejaculation (PE) is the most prevalent male sexual dysfunction, and the most recently defined. PE is often mistakenly considered a purely psychosexological symptom by patients: the lacking awareness in regards to the pathophysiology and treatments often lead to resignation from the patients' side, making PE the most underdiagnosed sexual complaint. However, an ever-growing body of evidence supporting several organic factors has been developed in the last decades and several definitions have been suggested to encompass all defining features of PE. In the present document by the Italian Society of Andrology and Sexual Medicine (SIAMS), we propose 33 recommendations concerning the definition, pathophysiology, treatment and management of PE aimed to improve patient care. These evidence-based clinical guidelines provide the necessary up-to-date guidance in the context of PE secondary to organic and psychosexological conditions, such as prostate inflammation, endocrine disorders, and other sexual dysfunctions, and suggest how to associate pharmacotherapies and cognitive-behavioral therapy in a couple-centered approach. New therapeutic options, as well as combination and off-label treatments, are also described.

Entities:  

Year:  2020        PMID: 33128158     DOI: 10.1007/s40618-020-01458-4

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  107 in total

Review 1.  Towards evidence-based drug treatment research on premature ejaculation: a critical evaluation of methodology.

Authors:  M D Waldinger
Journal:  Int J Impot Res       Date:  2003-10       Impact factor: 2.896

2.  Four measures of investigating ejaculatory performance.

Authors:  Marcel D Waldinger
Journal:  J Sex Med       Date:  2007-03       Impact factor: 3.802

3.  A case for clarity, consistency, and helpfulness: state-of-the-art clinical practice guidelines in endocrinology using the grading of recommendations, assessment, development, and evaluation system.

Authors:  Brian A Swiglo; M H Murad; Holger J Schünemann; Regina Kunz; Robert A Vigersky; Gordon H Guyatt; Victor M Montori
Journal:  J Clin Endocrinol Metab       Date:  2008-01-02       Impact factor: 5.958

Review 4.  An evidence-based unified definition of lifelong and acquired premature ejaculation: report of the second International Society for Sexual Medicine Ad Hoc Committee for the Definition of Premature Ejaculation.

Authors:  Ege Can Serefoglu; Chris G McMahon; Marcel D Waldinger; Stanley E Althof; Alan Shindel; Ganesh Adaikan; Edgardo F Becher; John Dean; Francois Giuliano; Wayne J G Hellstrom; Annamaria Giraldi; Sidney Glina; Luca Incrocci; Emmanuele Jannini; Marita McCabe; Sharon Parish; David Rowland; R Taylor Segraves; Ira Sharlip; Luiz Otavio Torres
Journal:  J Sex Med       Date:  2014-05-22       Impact factor: 3.802

5.  Opinions, Attitudes, and Perceptions in Relation to Erectile Dysfunction and Premature Ejaculation in the Undiagnosed Spanish Male Population. Results of the PANDORA Project.

Authors:  R Prieto-Castro; A M Puigvert-Martínez; R Artigas-Feliu; P Illán-Mateo; N Cruz-Culebra; M Artés-Ferragud
Journal:  J Sex Med       Date:  2020-07-01       Impact factor: 3.802

Review 6.  Differences between ICD-11 MMS and DSM-5 definition of premature ejaculation: a continuation of historical inadequacies and a source of serious misinterpretation by some European Regulatory Agencies (PART 2).

Authors:  Marcel D Waldinger; Dave H Schweitzer
Journal:  Int J Impot Res       Date:  2019-01-18       Impact factor: 2.896

7.  The serotonin transporter plays an important role in male sexual behavior: a study in serotonin transporter knockout rats.

Authors:  Johnny S W Chan; Eelke M S Snoeren; Edwin Cuppen; Marcel D Waldinger; Berend Olivier; Ronald S Oosting
Journal:  J Sex Med       Date:  2011-01       Impact factor: 3.802

Review 8.  Serotonin and premature ejaculation: from physiology to patient management.

Authors:  François Giuliano; Pierre Clément
Journal:  Eur Urol       Date:  2006-06-19       Impact factor: 20.096

9.  Serotonin transporter promoter region (5-HTTLPR) polymorphism is associated with the intravaginal ejaculation latency time in Dutch men with lifelong premature ejaculation.

Authors:  Paddy K C Janssen; Steven C Bakker; Janos Réthelyi; Aeilko H Zwinderman; Daan J Touw; Berend Olivier; Marcel D Waldinger
Journal:  J Sex Med       Date:  2009-01       Impact factor: 3.802

10.  The Sentiment Analysis of Tweets as a New Tool to Measure Public Perception of Male Erectile and Ejaculatory Dysfunctions.

Authors:  Andrea Sansone; Angelo Cignarelli; Giacomo Ciocca; Carlotta Pozza; Francesco Giorgino; Francesco Romanelli; Emmanuele A Jannini
Journal:  Sex Med       Date:  2019-08-05       Impact factor: 2.491

View more
  16 in total

Review 1.  Addressing male sexual and reproductive health in the wake of COVID-19 outbreak.

Authors:  A Sansone; D Mollaioli; G Ciocca; E Limoncin; E Colonnello; W Vena; E A Jannini
Journal:  J Endocrinol Invest       Date:  2020-07-13       Impact factor: 4.256

2.  Sperm cryopreservation during the SARS-CoV-2 pandemic.

Authors:  D Paoli; F Pallotti; G Nigro; A Aureli; A Perlorca; L Mazzuti; D Di Carlo; O Turriziani; A Lenzi; F Lombardo
Journal:  J Endocrinol Invest       Date:  2020-10-10       Impact factor: 4.256

3.  Tele-medicine versus face-to-face consultation in Endocrine Outpatients Clinic during COVID-19 outbreak: a single-center experience during the lockdown period.

Authors:  F Ceccato; G Voltan; C Sabbadin; V Camozzi; I Merante Boschin; C Mian; V Zanotto; D Donato; G Bordignon; A Capizzi; G Carretta; C Scaroni
Journal:  J Endocrinol Invest       Date:  2020-12-23       Impact factor: 4.256

4.  Effect of the COVID-19 pandemic and social distancing measures on the sexual functions of women treated for vaginismus (genitopelvic pain/penetration disorder).

Authors:  Funda Gungor Ugurlucan; Cenk Yasa; Muge Ates Tikiz; Ipek Evruke; Cansu Isik; Ozlem Dural; Suleyman Engin Akhan
Journal:  Int Urogynecol J       Date:  2021-02-19       Impact factor: 2.894

Review 5.  Facing Counterfeit Medications in Sexual Medicine. A Systematic Scoping Review on Social Strategies and Technological Solutions.

Authors:  Andrea Sansone; Béatrice Cuzin; Emmanuele A Jannini
Journal:  Sex Med       Date:  2021-10-04       Impact factor: 2.491

6.  Systemic steroids in patients with COVID-19: pros and contras, an endocrinological point of view.

Authors:  A M Berton; N Prencipe; R Giordano; E Ghigo; S Grottoli
Journal:  J Endocrinol Invest       Date:  2020-06-08       Impact factor: 4.256

7.  Impact of the SARS-CoV2 pandemic dissemination on the management of neuroendocrine neoplasia in Italy: a report from the Italian Association for Neuroendocrine Tumors (Itanet).

Authors:  F Panzuto; M Maccauro; D Campana; A Faggiano; S Massironi; S Pusceddu; F Spada; D Ferone; R Modica; C M Grana; P Ferolla; M Rinzivillo; G Badalamenti; M C Zatelli; F Gelsomino; E De Carlo; M Bartolomei; M P Brizzi; S Cingarlini; A Versari; G Fanciulli; E Arvat; E Merola; M Cives; S Tafuto; S Baldari; M Falconi
Journal:  J Endocrinol Invest       Date:  2020-08-16       Impact factor: 4.256

Review 8.  Gender susceptibility to COVID-19: a review of the putative role of sex hormones and X chromosome.

Authors:  C Foresta; M S Rocca; A Di Nisio
Journal:  J Endocrinol Invest       Date:  2020-09-16       Impact factor: 4.256

Review 9.  The Inferto-Sex Syndrome (ISS): sexual dysfunction in fertility care setting and assisted reproduction.

Authors:  G Luca; S Parrettini; A Sansone; R Calafiore; E A Jannini
Journal:  J Endocrinol Invest       Date:  2021-05-06       Impact factor: 4.256

10.  Serum concentrations of dihydrotestosterone are associated with symptoms of hypogonadism in biochemically eugonadal men.

Authors:  A Sansone; S Kliesch; M Dugas; R Sandhowe-Klaverkamp; A M Isidori; S Schlatt; M Zitzmann
Journal:  J Endocrinol Invest       Date:  2021-04-03       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.